Your session is about to expire
← Back to Search
Local Anesthetic
TAP Block- Exparel for Colon Cancer (TAP Trial)
N/A
Waitlist Available
Led By Robert K Cleary, MD
Research Sponsored by Saint Joseph Mercy Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients undergoing elective open and minimally invasive (laparoscopic and robotic) colon and rectal surgery for colorectal neoplasia, diverticulitis, and other diseases of the colon and rectum;
Surgical procedure either through standard open or minimal invasive approach (laparoscopic or robotic);
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative day 3
Awards & highlights
TAP Trial Summary
The primary outcome for this study is the Numeric Pain Score (NPS) for elective patients undergoing elective colorectal surgery that have been randomized to transversus abdominis plane block or epidural anesthesia for the management of perioperative pain in elective colorectal surgery.
Eligible Conditions
- Colon Cancer
- Colorectal Cancer
- Diverticulosis
TAP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTAP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-operative day 3
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative day 3
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Post-operative pain control day 1 using the numeric pain scale
Post-operative pain control day 2 using the numeric pain scale
Post-operative pain control day 3 using the numeric pain scale
Secondary outcome measures
Overall benefits of analgesia treatment post-operative day 1
Overall benefits of analgesia treatment post-operative day 2
Overall benefits of analgesia treatment post-operative day 3
Other outcome measures
Patient use of supplemental narcotic analgesia post-operative day 1
Patient use of supplemental narcotic analgesia post-operative day 2
Patient use of supplemental narcotic analgesia post-operative day 3
TAP Trial Design
2Treatment groups
Active Control
Group I: TAP Block- ExparelActive Control1 Intervention
Transversus abdominis plane block utilizing the medication Exparel®
Group II: Continuous Epidural AnalgesiaActive Control1 Intervention
Continuous Epidural Analgesia
Find a Location
Who is running the clinical trial?
Saint Joseph Mercy Health SystemLead Sponsor
12 Previous Clinical Trials
6,105 Total Patients Enrolled
Robert K Cleary, MDPrincipal InvestigatorSaint Joseph Mercy Hospital
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger